EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Fluorogenic platinum( iv ) complexes as potential predictors for the design of hypoxia-activated platinum( iv ) prodrugs

Jevon W Marsh, Lina Hacker iD, Shitong Huang, Marie H C Boulet, Jhanelle R G White, Louise A W Martin, Megan A Yeomans, Hai-Hao Han iD, Ismael Diez-Perez iD, Rebecca A Musgrave iD, Ester M Hammond iD, Adam C Sedgwick iD

Dalton Transactions · 2024

DOI: 10.1039/d4dt02173h ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Jevon W Marsh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, UK. adam.sedgwick@kcl.ac.uk. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Fluorescent Dyes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: University of Oxford, Jesus College, University of Oxford, King’s College London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this work, we have developed and demonstrated the utility of fluorogenic Pt(IV) complexes to help predict the design of a hypoxia-activated platinum(IV) (HAPt) prodrug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsFluorescent DyesHumansOrganoplatinum CompoundsDrug DesignCell Line, TumorCell HypoxiaCell SurvivalMolecular StructureStructure-Activity RelationshipDrug Screening Assays, AntitumorPlatinumCoordination Complexes

Substanzen

ProdrugsAntineoplastic AgentsFluorescent DyesOrganoplatinum CompoundsPlatinumCoordination Complexes

Autor:innen und Institutionen

  • Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, UK. adam.sedgwick@kcl.ac.uk.
  • Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK. ester.hammond@oncology.ox.ac.uk.
  • Department of Chemistry, King's College London, 7 Trinity Street, London, SE1 1DB, UK.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, P. R. China.

ORCID-Profile: Lina Hacker, Hai-Hao Han, Ismael Diez-Perez, Rebecca A Musgrave, Ester M Hammond, Adam C Sedgwick

Förderung

  • University of Oxford
  • Jesus College, University of Oxford
  • King’s College London
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Marsh, J. W., Hacker, L., Huang, S., Boulet, M. H. C., White, J. R. G., Martin, L. A. W., Yeomans, M. A., Han, H. H., Diez-Perez, I., Musgrave, R. A., Hammond, E. M., & Sedgwick, A. C. (2024). Fluorogenic platinum( iv ) complexes as potential predictors for the design of hypoxia-activated platinum( iv ) prodrugs. Dalton Transactions. https://doi.org/10.1039/d4dt02173h

Vancouver

Marsh JW, Hacker L, Huang S, Boulet MHC, White JRG, Martin LAW, et al. Fluorogenic platinum( iv ) complexes as potential predictors for the design of hypoxia-activated platinum( iv ) prodrugs. Dalton Transactions. 2024. doi:10.1039/d4dt02173h

BibTeX
@article{Marsh2024,
  author = {Marsh, Jevon W and Hacker, Lina and Huang, Shitong and Boulet, Marie H C and White, Jhanelle R G and Martin, Louise A W and Yeomans, Megan A and Han, Hai-Hao and Diez-Perez, Ismael and Musgrave, Rebecca A and Hammond, Ester M and Sedgwick, Adam C},
  title = {Fluorogenic platinum( iv ) complexes as potential predictors for the design of hypoxia-activated platinum( iv ) prodrugs},
  journal = {Dalton Transactions},
  year = {2024},
  doi = {10.1039/d4dt02173h}
}
Kostenlos starten →